Global Gemtuzumab Ozogamicin Market Rising in Demands and Growth Insights till Forecast 2024 to 2034
Global Gemtuzumab Ozogamicin Overview:
AML is the main condition for which Global Gemtuzumab Ozogamicin Market is used as a targeted cancer therapy. It is a monoclonal antibody-drug conjugate (ADC) that mixes calicheamicin, a cytotoxic agent, with another medication. The monoclonal antibody present in gemtuzumab ozogamicin is engineered to identify and attach itself to CD33, a protein that is frequently present on the surface of AML cells. The powerful cytotoxic agent calicheamicin is released by the medication once it h
Like
Comment
Share
